Mucomyst (Acetylcysteine)

Acetylcysteine, the active ingredient in Mucomyst, is a mucolytic presented as a solution for inhalation use. It reduces mucus viscosity and is employed to improve airway clearance in chronic bronchopulmonary diseases, cystic fibrosis and after exposure to irritant gases.

GNH USA supplies Mucomyst as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mucomyst is a mucolytic that acts on respiratory secretions to facilitate clearance in several chronic and acute conditions.

- Chronic bronchopulmonary diseases (e.g., COPD, chronic bronchitis): improves mucus clearance and eases breathing. - Cystic fibrosis: helps liquefy thick secretions, supporting airway hygiene. - Exposure to irritant gases (e.g., chlorine, ammonia): reduces risk of bronchospasm by thinning airway mucus.

Acetylcysteine may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Cough or throat irritation during inhalation. - Bronchospasm, especially in patients with reactive airways. - Nausea or mild gastrointestinal discomfort. - Unpleasant taste or odor. - Headache. - Mild dizziness.

Serious or Rare Side Effects: - Anaphylactic reaction or severe hypersensitivity. - Severe bronchospasm requiring medical intervention. - Angioedema involving face or airway. - Pulmonary edema. - Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Significant hypotension.

Before initiating Mucomyst, clinicians should consider several safety measures.

- Assess airway reactivity: perform bronchial provocation testing in patients with known asthma. - Monitor for bronchospasm: observe the patient during the first inhalation session. - Avoid in individuals with documented hypersensitivity to acetylcysteine or its excipients. - Use cautiously in patients with active peptic ulcer disease, as irritation may be increased. - Pregnancy and lactation: consult the prescriber because safety data are limited. - Store at room temperature: keep in the original container, protect from moisture and light.

Acetylcysteine can interact with other medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Nitroglycerin: concurrent use may precipitate severe hypotension. - Activated charcoal: can reduce drug absorption if administered orally.

Moderate Interactions (Monitor Closely): - Bronchodilators: may increase the risk of bronchospasm in hyperreactive airways. - Other mucolytics: additive irritation of the respiratory tract. - Anticoagulants: potential for enhanced bleeding tendency, requiring monitoring of coagulation parameters.